Pre-publication history
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non–small cell lung cancer (WJOG 5910L)
BMC Cancer 2012, 12:327 doi:10.1186/1471-2407-12-327
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 10 Aug 2011 | |
| Reviewer's Report | Primo Lara | 27 Apr 2012 | |
| Reviewer's Report | David Spigel | 11 Jun 2012 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 05 Jul 2012 |
| Editorial acceptance | 18 Jul 2012 | ||
| Published | 01 Aug 2012 |
